| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8263364 | Experimental Gerontology | 2015 | 8 Pages | 
Abstract
												Sarcopenia seems to be associated with many harmful clinical components making this geriatric syndrome a real public health burden. Follow-up data of the SarcoPhAge study will be helpful to assess the outcomes of sarcopenia based on the EWGSOP diagnosis algorithm and its different proposed cut-offs.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Ageing
												
											Authors
												C. Beaudart, J.Y. Reginster, J. Petermans, S. Gillain, A. Quabron, M. Locquet, J. Slomian, F. Buckinx, O. Bruyère, 
											